Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Hemostemix Inc. V.HEM

Sector: Healthcare | Sub-Sector: Biotechnology

Hemostemix Inc is a biotechnology company. The Company is engaged in developing, manufacturing and commercializing adult stem cell therapies to treat a variety of diseases.
Price: $0.80 | Change: $-0.03 | %Change: -3.61%
Volume: 37,000 | Day High/Low: 0.85/0.80 | 52 Week High/Low: 1.25/0.55
View modes: 
1 star

New presentation

https://www.dropbox.com/s/ri5su3ojyv3tiwg/Hemostemix%20Investor%20Presentation%2020150520.pptx?dl=0  rate and reply
5 stars

RE:Q4 md&a is out

They have patents for neural and bone ip that I was not aware of. Perhaps it is just pie in the sky though.  rate and reply
1 star

Q4 md&a is out

Pg 5 and 6 list the go forward plans for P2 finishing enrolling at the end of 2016 and Phase 3 trials after a small study is completed. Also potential for marketing product in other countries where it...read more
1 star

hearing

this is the place to be,so my broker says.  rate and reply
3 stars

CEO blog

http://www.hemostemix.com/index.php/media-sidenav/2015-02-24-sidenav.html Welcome to my first-ever blog post, as I share milestones in the Hemostemix story with patients, employees, and investors.  ...read more
1 star

RE:RE:Might be into revenue in a year

They did an untaped presentation. I don't waste people's time with false info like that fool who got all his posts deleted.  rate and reply
5 stars

RE:Might be into revenue in a year

Eunice12.  I share your enthusiasm for HEM but to my knowledge there has not been any announcement on the number of patients enrolled in the study to-date.  Your number may be quite inaccurate...read more
1 star

RE:Might be into revenue in a year

With good results, they will move into other blood vessel therapies, like cardiac. They also hope for benefits to people with PAD who do not have serious problems yet, as a preventative therapy once a...read more
1 star

Might be into revenue in a year

They are way more advanced than I thought. 99 patients already enrolled (and more all the time) in an efficacy  study that is 1/3 placebo- if 60 reach the target end point then the placebo is...read more
3 stars

Fur ears just posts on days when it goes down

He started when it was in  the 60s, for those who think he has any clues, which he doesn't.  rate and reply
1 star

RE:crazy volume

Only you would be stupid enough to try to make indirect comments to escape a defamation suit. I am thinking even more of sicking hemo lawyers on you because this last post continues the insinuation of...read more
0 stars

RE:Don't be sucked in

How the heck would you know what the mkt cap should be on a bio tec currently in phase 2 trials . Yhe market bares what the mkt bares. Stock will be much higer come Feb  rate and reply
3.5 stars

RE:Don't be sucked in

Don't pay any attention to liar rabbit. I might sick Hemo lawyers on him for defamation like I have seen happen on other boards when a chronic liar shows up. Everyone knows the days of people being...read more
0 stars

All in good fun

Merry Christmas to everyone.  rate and reply
0 stars

Silly Rabbit

Trix are for kids. Stock trading is not.  rate and reply
0 stars

HEM Trading at $1.10

Looking good. Stock should be more liquid at the $1.50 range.  rate and reply
0 stars

New presentation Dec 15.

Then we will be able to talk about HEM, instead of reading Rabbit fables from the lying fool.  rate and reply
0 stars

RE:About to fall off a cliff

Havent used these boards before. Was warned about the calibre of posts. Now I get it.Yeah just about to fall off a cliff. That makes sense. Stock gets rolled back after a financing, raise $3.5 million...read more
0 stars

RE:RE:Management

Still early. Dr. Buchardt hasnt appointed new directors yet which Im sure he will soon,  rate and reply
0 stars

Management

Agreed. Great team. I'm sure as things progress Dr. Burchard will bring along more of his contempraries from big Pharma to round out the team.  rate and reply